Tech company, Second Sight Medical Products, has made a remarkable breakthrough in developing the “bionic eye” that they say can restore vision to patients with visual impairment.
Merck and Co. has developed the breakthrough drug, Pembrolizumab, that is the first in its class to be approved by the US Food and Drug Administration for use against melanoma.
A drug that is currently being used to treat heart disease could potentially be repurposed to treat the Ebola virus. Researchers are in the process of refining the drug’s action so that it could be used against the deadly virus.
And undiagnosed disease claims the life of two-year-old Isabel Haifley. She was waiting in line for a lung transplant when she succumbed to her disease after staying in the hospital for 45 days.